BAUDAX BIO INC's ticker is BXRX and the CUSIP is 07160F107. A total of 56 filers reported holding BAUDAX BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,926,000 | – | 278,370 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH RUN CAPITAL, LP | 1,152,539 | $4,783,000 | 6.56% |
Corsair Capital Management | 870,123 | $3,611,000 | 1.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 157,220 | $652,000 | 0.26% |
Leap Investments LP | 19,000 | $79,000 | 0.05% |
Alyeska Investment Group, L.P. | 815,384 | $3,384,000 | 0.05% |
Ikarian Capital, LLC | 100,000 | $415,000 | 0.03% |
Brandywine Global Investment Management, LLC | 187,252 | $778,000 | 0.01% |
OLD MISSION CAPITAL LLC | 19,600 | $81,000 | 0.01% |
Paloma Partners Management Co | 48,744 | $202,000 | 0.00% |
Verition Fund Management LLC | 27,000 | $112,000 | 0.00% |